...
首页> 外文期刊>The Journal of Antimicrobial Chemotherapy >Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters
【24h】

Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters

机译:BAL30072单独或与β-内酰胺酶抑制剂或美罗培南联用对耐碳青霉烯的肠杆菌科细菌和非发酵菌的活性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objectives: We investigated the activity of BAL30072, a dihydroxypyridone monosulfactam, against carbapenem- resistant Enterobacteriaceae and non-fermenters (i) alone, (ii) combined with BAL29880 (to inhibit AmpC) and/or clavulanate [to inhibit extended-spectrum β-lactamases (ESBLs)] and (iii) combined 1:1 with meropenem. Methods: Isolates were from multiple UK hospitals. MICs were determined by CLSI agar dilution. Carbapenemases were identified by PCR and sequencing. Results: BAL30072 inhibited 69% of the carbapenem-resistant Enterobacteriaceae at ≤4 mg/L, including 60%- 87% with OXA-48, IMP, NDM and VIM enzymes or combinations of impermeability with AmpC or ESBL, and 40% with KPC enzymes. The proportions susceptible exceeded 90% for BAL30072+BAL29880+clavulanate, except for isolates with KPC carbapenemases, where members of the international sequence type (ST) 258 Klebsiella pneumoniae clone remained resistant. At 4 mg/L, BAL30072 was active against all OprD-deficient Pseudomonas aeruginosa, against 8/12 with efflux-type β-lactam resistance and 19/25 with metallo-carbapenemases; these proportions were little increased if inhibitors were added. Most Acinetobacter baumannii with OXA or NDM carbapenemases were susceptible to BAL30072 alone at ≤4 mg/L, but those with OXA-58 were resistant, probably for reasons other than their β-lactamase. Addition of meropenem to BAL30072 increased activity against some individual isolates, but with little clear relationship to the resistance mechanism, except for consistent potentiation against OprD-deficient P. aeruginosa. Conclusions: BAL30072 had good activity against many diverse carbapenem resistance types. Adding clavulanate and/or BAL29880 extended activity against carbapenem-resistant Enterobacteriaceae, but not non-fermenters. Adding meropenem resulted in small increases in activity against individual isolates. Resistance remained common in the K. pneumoniae ST258 KPC clone, even with both inhibitors or meropenem added.
机译:目的:我们研究了二羟基吡啶酮单磺内酰胺BAL30072对耐碳青霉烯的肠杆菌科细菌和非发酵菌的活性(i)单独使用,(ii)结合BAL29880(抑制AmpC)和/或克拉维酸盐[抑制广谱β-内酰胺酶(ESBLs)]和(iii)与美罗培南1:1组合。方法:分离物来自英国多家医院。通过CLSI琼脂稀释法测定MIC。通过PCR和测序鉴定碳青霉烯酶。结果:BAL30072在≤4 mg / L时抑制69%的耐碳青霉烯的肠杆菌科细菌,包括OXA-48,IMP,NDM和VIM酶或与AmpC或ESBL具有不渗透性的组合的60%-87%,与KPC的结合的40%酶。 BAL30072 + BAL29880 +克拉维酸盐的易感比例超过90%,但带有KPC碳青霉烯酶的分离株除外,其中国际序列类型(ST)258肺炎克雷伯菌的成员仍具有抗性。在4 mg / L时,BAL30072对所有OprD缺陷型铜绿假单胞菌有活性,对8/12的外排型β-内酰胺耐药,对19/25的金属卡宾滨膜有活性。如果添加抑制剂,这些比例几乎没有增加。大多数带有OXA或NDM碳青霉烯酶的鲍曼不动杆菌仅对BAL30072敏感,≤4mg / L,但对OXA-58的那些不敏感,可能是由于其β-内酰胺酶以外的原因。将美罗培南添加到BAL30072中可以提高针对某些分离株的活性,但与抗药性机制之间几乎没有明确的关系,除了对OprD缺陷型铜绿假单胞菌的持续增强作用外。结论:BAL30072对许多不同的碳青霉烯耐药类型具有良好的活性。添加克拉维酸盐和/或BAL29880延长了对耐碳青霉烯的肠杆菌科细菌的活性,但对非发酵菌却没有。添加美罗培南导致针对个别分离株的活性略有增加。即使添加了两种抑制剂或美罗培南,抗药性在肺炎克雷伯菌ST258 KPC克隆中仍然很常见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号